Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat

By Xing-San L.   Qing-Dong W.   John P.  

European Journal of Pharmacology, Vol. 283, Iss. 1, 1995-09 ,pp. : 161-168

Elsevier

Access to resources Recommend Favorite

Effects of TAK-637, a tachykinin receptor antagonist, on the micturition reflex in guinea pigs

By Doi T.   Kamo I.   Imai S.   Okanishi S.   Ikeura Y.   Natsugari H.  

European Journal of Pharmacology, Vol. 395, Iss. 3, 2000-05 ,pp. : 241-246

Elsevier

Access to resources Recommend Favorite

Hemodynamic effects of MF 10058, a new cardioselective muscarinic M 2 receptor antagonist, in conscious dogs

By Lamperti G.   Champeroux P.   Martel E.   Colibretti M.L.   Santoro L.   Imbimbo B.P.  

European Journal of Pharmacology, Vol. 406, Iss. 1, 2000-10 ,pp. : 93-98

Elsevier

Access to resources Recommend Favorite

Effects of TAK-637, a tachykinin receptor antagonist, on lower urinary tract function in the guinea pig

By Doi T.   Kamo I.   Imai S.   Okanishi S.   Ishimaru T.   Ikeura Y.   Natsugari H.  

European Journal of Pharmacology, Vol. 383, Iss. 3, 1999-11 ,pp. : 297-303

Elsevier

Access to resources Recommend Favorite

Bosentan: a dual endothelin receptor antagonist

By Roux Sébastien   Rubin Lewis J  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 7, 2002-07 ,pp. : 991-1002

Informa Healthcare

Access to resources Recommend Favorite